| Description | Levofloxacin sodium is a synthetic fluoroquinolones antibacterial. It inhibits the supercoiling activity of bacterial DNA gyrase, so that halting DNA replication. |
| molecular weight | 384.363 |
| Molecular formula | C18H20FN3NaO4 |
| CAS | 872606-49-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Fayyaz M, Yousuf RI, Shoaib MH, Ali T, Nasiri I, Ashraf N. Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets. Pak J Pharm Sci. 2015 Jan;28(1):119-28. PubMed PMID: 25553690. 2. Türkeş C, Söyüt H, Beydemir Ş. Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. J Enzyme Inhib Med Chem. 2015;30(4):622-8. doi: 10.3109/14756366.2014.959511. Epub 2014 Dec 18. PubMed PMID: 25519764. 3. Sun H, Wang H, Ge X. Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography. J Clin Lab Anal. 2012 Nov;26(6):486-92. doi: 10.1002/jcla.21551. PubMed PMID: 23143633. 4. Fleischbein E, Montgomery PA, Zhou CS. Visual compatibility of micafungin sodium and levofloxacin injections. Am J Health Syst Pharm. 2012 Dec 15;69(24):2130. doi: 10.2146/ajhp120484. PubMed PMID: 23230033. |